ARCHIVES

ODAC Rejects Amsacrine NDA, Renews Idarubicin

This article is from The Cancer Letter archive.

Vol. 16 No. 35 | September 14, 1990

Download PDF Visit The Full Archive

Related Articles

Rauscher Responds To Criticism

March 21, 1975

Over $20 Million Carved Out From Statistical, Operations Centers

May 16, 2014

In Brief: Three NCI Basic Science Centers Rank In Index Of Citations; Novello: Help More Smokers Quit

August 2, 1991

DeVita Dissatisfied With Cooperative Groups on Accrual; NCAB to Hear Wittes’ Plan In Feb.

November 20, 1987

Clinical Trials Approved In August 2002 By NCI

September 27, 2002

NIH Carcinogen Guidelines Offered

April 24, 1981